USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Episurf Ip-management AB

USPTO PatentsView assignee record - 37 granted patents across 15 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Episurf ranks #8,581 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 15 technology areas.

#8,581
of 49,997 US assignees by volume
Top 43%
by Innovation Score (37.8/100)
12.8
avg claims per patent
+77%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8581 · Foreign Corporation #8,581 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 37 grants
  • UPPER-Q #8,581/49,997
  • PHOTO-FINISH Decision Sciences…
  • CPC-FOCUS A61F · 15 areas
  • INNOV-THIN 37.8/100
  • CLAIMS-RICH 12.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +77% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Decision Sciences International Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Episurf’s 37.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Episurf

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Episurf's Innovation Score is 37.8/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Episurf?

Each dot is one of Episurf’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Episurf’s own 12.8 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Episurf vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 36.937.037.03737.037.037.1 0510152025 Granted patents (volume) Avg claims / patent Decision Sciences International Corporation - 37, 22.84Decision Sciences…Diamet Corporation - 37, 8.41DiametDigitalOptics Corporation Mems - 37, 20.43Digitaloptics MemsElesa S.P.A. - 37, 3.68Elesa S P AExemplar Design, LLC - 37, 6.03Exemplar DesignFanuc America Corporation - 37, 19.16Fanuc AmericaFlir Unmanned Aerial Systems ULC - 37, 19.95Flir Unmanned Aer…Flow Control LLC - 37, 15.95Flow ControlEpisurf Ip-management AB - 37, 12.76Episurf Ip-manage…
Episurf vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Episurf's grants concentrate

Episurf Ip-management AB is a focused PatentsView assignee: 15 CPC subclasses with 67.6% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (7 grants) versus a trough of 2 in 2016. By volume, Episurf sits between Decision Sciences International Corporation and Flow Control LLC.

Episurf's three-year grant acceleration

Episurf Ip-management AB shows 11 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Episurf's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Episurf holds 37 patents at rank #8,581, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Episurf

By rank, the assignees closest to #8,581 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Episurf's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Episurf, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Episurf ranks #260 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Episurf's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Episurf Ip-management AB patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 5.4%
2017 2 5.4%
2018 2 5.4%
2019 7 18.9%
2020 6 16.2%
2021 6 16.2%
2022 5 13.5%
2023 2 5.4%
2024 4 10.8%
2025partial year 1 2.7%

Which technologies does Episurf Ip-management AB patent most?

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Episurf Ip-management AB's patent record in context - here's where to go next.

  • Episurf Ip-management AB's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 67.6% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #8,581 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Episurf Ip-management AB against Decision Sciences International Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.